Tianjin Development Holdings Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Development Holdings Limited with three other
companies in this sector in Hong Kong:
CK Life Sciences Intl (Holdings) Inc
sales of 5.23 billion Hong Kong Dollars [US$668.51 million]
of which 56%
China Shineway Pharmaceutical Group Limited
(3.04 billion Hong Kong Dollars [US$388.70 million]
of which 52%
was Injections), and
China Grand Pharmaceutical and Healthcare Holdings Limited
(5.96 billion Hong Kong Dollars [US$761.18 million]
of which 60%
was Manufacture and sales of pharmaceutical ).
During the year ended December of 2018, sales at
Tianjin Development Holdings Limited were HK$5.39 billion (US$688.76 million).
decrease of 22.8%
versus 2017, when the company's sales were HK$6.99 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Tianjin Development Holdings Limited had sales
of HK$4.95 billion.
Contributing to the drop in overall sales was the 62.6% decline
in Utilities, from HK$3.87 billion to HK$1.44 billion.
However, these declines were partially offset by the increase in sales of
Pharmaceutical (up 37.1% to HK$2.57 billion)
Electrical and Mechanical (up 10.4% to HK$1.24 billion)
Hotels (up 9.4% to HK$127.74 million)